Claritas Rx Partners with Relay Network to Boost Specialty Drug Patient Engagement

  • Claritas Rx and Relay Network have formed a strategic partnership to enhance patient engagement for specialty and rare disease programs.
  • The collaboration combines Claritas Rx’s patient journey data with Relay Network’s mobile-first engagement platform.
  • The joint offering aims to improve patient onboarding, adherence, and long-term therapy persistence.
  • An upcoming webinar on October 14, 2026, will discuss insights from 1.5 million patient interactions.

The partnership addresses the growing need for more effective patient engagement in the specialty and rare disease sectors, where traditional communication methods like email and phone calls are increasingly ineffective. By leveraging mobile-first technologies and deep patient journey insights, the collaboration aims to fill critical gaps in patient access, support, and adherence. This trend reflects a broader industry shift towards digital health solutions that enhance patient outcomes and operational efficiency.

Integration Success
How effectively Claritas Rx and Relay Network integrate their technologies to deliver seamless patient experiences.
Market Adoption
The pace at which biopharma companies adopt this joint solution for specialty and rare disease programs.
Regulatory Compliance
Whether the HIPAA-compliant platform can maintain compliance while expanding its patient engagement capabilities.